Reversal of nitroglycerin tolerance in coronary artery disease

D. C. May, L. D. Hillis

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Tolerance to a sustained infusion of nitroglycerin is known to develop in patients being treated for angina pectoris. The mechanism by which this occurs is not well understood, but is linked to molecular changes in vascular smooth muscle cells. Our study showed that tolerance to nitroglycerin develops in coronary arteries and that it can be reversed by introducing a sulfhydryl-rich compound, N-acetylcysteine.

Original languageEnglish (US)
Title of host publicationCardiology Board Review
Volume5
Edition3
StatePublished - 1988
Externally publishedYes

Fingerprint

Nitroglycerin
Coronary Artery Disease
Acetylcysteine
Angina Pectoris
Vascular Smooth Muscle
Sulfhydryl Compounds
Smooth Muscle Myocytes
Coronary Vessels

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

May, D. C., & Hillis, L. D. (1988). Reversal of nitroglycerin tolerance in coronary artery disease. In Cardiology Board Review (3 ed., Vol. 5)

Reversal of nitroglycerin tolerance in coronary artery disease. / May, D. C.; Hillis, L. D.

Cardiology Board Review. Vol. 5 3. ed. 1988.

Research output: Chapter in Book/Report/Conference proceedingChapter

May, DC & Hillis, LD 1988, Reversal of nitroglycerin tolerance in coronary artery disease. in Cardiology Board Review. 3 edn, vol. 5.
May DC, Hillis LD. Reversal of nitroglycerin tolerance in coronary artery disease. In Cardiology Board Review. 3 ed. Vol. 5. 1988
May, D. C. ; Hillis, L. D. / Reversal of nitroglycerin tolerance in coronary artery disease. Cardiology Board Review. Vol. 5 3. ed. 1988.
@inbook{c23943e6062141d1a9ba2289cc41bc47,
title = "Reversal of nitroglycerin tolerance in coronary artery disease",
abstract = "Tolerance to a sustained infusion of nitroglycerin is known to develop in patients being treated for angina pectoris. The mechanism by which this occurs is not well understood, but is linked to molecular changes in vascular smooth muscle cells. Our study showed that tolerance to nitroglycerin develops in coronary arteries and that it can be reversed by introducing a sulfhydryl-rich compound, N-acetylcysteine.",
author = "May, {D. C.} and Hillis, {L. D.}",
year = "1988",
language = "English (US)",
volume = "5",
booktitle = "Cardiology Board Review",
edition = "3",

}

TY - CHAP

T1 - Reversal of nitroglycerin tolerance in coronary artery disease

AU - May, D. C.

AU - Hillis, L. D.

PY - 1988

Y1 - 1988

N2 - Tolerance to a sustained infusion of nitroglycerin is known to develop in patients being treated for angina pectoris. The mechanism by which this occurs is not well understood, but is linked to molecular changes in vascular smooth muscle cells. Our study showed that tolerance to nitroglycerin develops in coronary arteries and that it can be reversed by introducing a sulfhydryl-rich compound, N-acetylcysteine.

AB - Tolerance to a sustained infusion of nitroglycerin is known to develop in patients being treated for angina pectoris. The mechanism by which this occurs is not well understood, but is linked to molecular changes in vascular smooth muscle cells. Our study showed that tolerance to nitroglycerin develops in coronary arteries and that it can be reversed by introducing a sulfhydryl-rich compound, N-acetylcysteine.

UR - http://www.scopus.com/inward/record.url?scp=0023882623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023882623&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:0023882623

VL - 5

BT - Cardiology Board Review

ER -